Overexpression of DLX2 is associated with poor prognosis and sorafenib resistance in hepatocellular carcinoma.
| Image |  |
|---|---|
| Description | scientific article published on 11 June 2016 |
| Author/s |
author: Runzhou Ni |
| Publication date | June 11, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |